acetylcysteine has been researched along with Ventricular Dysfunction, Left in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, RF; Li, B; Li, L; Qin, FZ; Wang, AL; Wang, K; Xi, J; Yang, H; Yang, LG; Zhang, C; Zhu, ZF | 1 |
| Chen, TH; Liao, FT; Wang, JC; Wang, JJ; Wu, NC; Yang, YC | 1 |
| Dasgupta, C; Huang, X; Li, Y; Wang, L; Xiao, D; Zhang, L | 1 |
| Bonomo, C; Bueno, RT; Cezar, MD; Damatto, RL; Fernandes, DC; Guizoni, DM; Junior, SA; Laurindo, FR; Lima, AR; Martinez, PF; Okoshi, K; Okoshi, MP; Pagan, LU; Seiva, FR; Zornoff, LA | 1 |
| Abdel-Qadir, H; Amir, E; Fazelzad, R; Lee, DS; Ong, G; Thavendiranathan, P; Tomlinson, G | 1 |
| Chapman, D; Dhalla, NS; Elimban, V; Maddika, S | 1 |
| Boontje, NM; de Crom, R; de Waard, MC; Dekkers, DH; Duncker, DJ; Kuster, DW; Lamers, JM; van der Velden, J; van Haperen, R | 1 |
| Albini, A; Cammarota, R; De Flora, S; Donatelli, F; Noonan, DM; Pennesi, G | 1 |
| Chun, DH; Hong, SW; Kim, JC; Kwak, YL; Shim, JK; Yoo, KJ | 1 |
| Adamy, C; Adubeiro, S; Badoual, T; Bourin, MC; Bourraindeloup, M; Cailleret, M; Candiani, G; Dubois-Rande, JL; Hittinger, L; Pecker, F; Roudot-Thoraval, F; Su, JB | 1 |
| Bhatnagar, A; Cai, J; Gu, Y; Hill, BG; Luo, J; Prabhu, SD; Srivastava, S | 1 |
| Elmes, MJ; Gardner, DS; Langley-Evans, SC; McMullen, S | 1 |
| Anning, PB; Grocott-Mason, RM; Lewis, MJ | 1 |
| Gare, M; Kehl, F; Kersten, JR; Mraovic, B; Pagel, PS; Warltier, DC | 1 |
2 review(s) available for acetylcysteine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left | 2017 |
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Blood Coagulation; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Flavonoids; Free Radical Scavengers; Heart; Humans; Hypertension; Patient Care Team; Phenols; Platelet Aggregation Inhibitors; Polyphenols; Stroke Volume; Venous Thromboembolism; Ventricular Dysfunction, Left | 2010 |
1 trial(s) available for acetylcysteine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery.
Topics: Acetylcysteine; Acute Lung Injury; Aged; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass, Off-Pump; Creatine Kinase; Double-Blind Method; Female; Free Radical Scavengers; Hemodynamics; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pulmonary Circulation; Respiratory Function Tests; Vascular Resistance; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 2011 |
11 other study(ies) available for acetylcysteine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats.
Topics: Acetylcysteine; Animals; Autophagy; Blood Pressure; Echocardiography; Heart Failure; Male; Myocytes, Cardiac; Necroptosis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2022 |
N-acetylcysteine improves cardiac contractility and ameliorates myocardial injury in a rat model of lung ischemia and reperfusion injury.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Bronchoalveolar Lavage Fluid; Creatine Kinase, MB Form; Cytoprotection; Disease Models, Animal; Hydroxyl Radical; Lipid Peroxidation; Lung; Lung Injury; Male; Myocardial Contraction; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors; Troponin I; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2013 |
Protective Effect of Antenatal Antioxidant on Nicotine-Induced Heart Ischemia-Sensitive Phenotype in Rat Offspring.
Topics: Acetylcysteine; Animals; Antioxidants; Coronary Circulation; Disease Susceptibility; Drug Evaluation, Preclinical; Female; Fetus; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Infusion Pumps, Implantable; Male; Models, Biological; Myocardial Ischemia; Myocardial Reperfusion Injury; Nicotine; Oxidative Stress; Phenotype; Phosphorylation; Pregnancy; Prenatal Exposure Delayed Effects; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Ventricular Dysfunction, Left | 2016 |
Modulation of MAPK and NF-954;B Signaling Pathways by Antioxidant Therapy in Skeletal Muscle of Heart Failure Rats.
Topics: Acetylcysteine; Animals; Antioxidants; Blotting, Western; Echocardiography; Gene Expression; Heart Failure; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Myocardial Infarction; MyoD Protein; Myogenin; NF-kappa B; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Ventricular Dysfunction, Left | 2016 |
Role of oxidative stress in ischemia-reperfusion-induced alterations in myofibrillar ATPase activities and gene expression in the heart.
Topics: Acetylcysteine; Animals; Antioxidants; Calcium-Transporting ATPases; Cardiac Myosins; Catalase; Enzyme Inhibitors; Gene Expression Regulation; In Vitro Techniques; Leupeptins; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Myofibrils; Myosin Heavy Chains; Myosin Light Chains; Oxidative Stress; Perfusion; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Ventricular Dysfunction, Left; Ventricular Pressure; Xanthine; Xanthine Oxidase | 2009 |
Detrimental effect of combined exercise training and eNOS overexpression on cardiac function after myocardial infarction.
Topics: Acetylcysteine; Actin Cytoskeleton; Animals; Antioxidants; Arginine; Biopterins; Disease Models, Animal; Exercise Therapy; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Physical Exertion; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Superoxides; Time Factors; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Pressure; Ventricular Remodeling | 2009 |
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Collagen; Disease Progression; Drug Evaluation, Preclinical; Glutathione; Heart Ventricles; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Sodium Chloride, Dietary; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure.
Topics: Acetylcysteine; Acrolein; Aldehydes; Animals; Antioxidants; Calcium Signaling; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Environmental Exposure; Environmental Pollutants; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Oxidative Stress; Protein Carbonylation; Proteomics; Risk Assessment; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfhydryl Compounds; Ventricular Dysfunction, Left; Ventricular Pressure | 2007 |
Prenatal diet determines susceptibility to cardiac ischaemia-reperfusion injury following treatment with diethylmaleic acid and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Diet, Protein-Restricted; Disease Models, Animal; Female; Glutathione; Heart; Hemodynamics; Maleates; Maternal Exposure; Myocardial Reperfusion Injury; Myocardium; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Rats; Ventricular Dysfunction, Left | 2008 |
Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diastole; Female; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hemoglobins; Isoquinolines; Lisinopril; Male; Muscle Relaxation; Nitric Oxide; Receptor, Bradykinin B2; Simethicone; Stroke Volume; Sulfhydryl Compounds; Superoxide Dismutase; Systole; Tetrahydroisoquinolines; Ventricular Dysfunction, Left | 1997 |
Reactive oxygen species contribute to contractile dysfunction following rapid ventricular pacing in dogs.
Topics: Acetylcysteine; Analysis of Variance; Animals; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Female; Free Radical Scavengers; Heart Function Tests; Hemodynamics; Male; Myocardial Contraction; Myocardial Stunning; Probability; Random Allocation; Reactive Oxygen Species; Reference Values; Stroke Volume; Ventricular Dysfunction, Left | 2002 |